Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
5/9/2013 10:09:25 AM
More...
|
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Announce Preliminary Selection of Lead Compound for Treating Type 2 Diabetes
8/16/2012 10:48:35 AM
More...
|
Unigene Laboratories, Inc. (UGNE) to Host Live Conference Call and Webcast to Discuss Collaboration with Nordic Bioscience A/S and Formation of Joint Development Vehicle
10/6/2011 10:08:00 AM
More...
|
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Combine Industry Leading Capabilities to Advance Unigene's Proprietary Peptides through Phase 2 Proof-of-Concept for the Treatment of Type 2 Diabetes, Osteoarthritis and Osteoporosis
10/6/2011 9:54:50 AM
More...
|
Emisphere Technologies, Inc. (EMIS), Novartis Pharma AG (NVS). Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Emisphere Stock Falls 61.15% at 1:37PM EDT
7/23/2010 7:08:08 AM
More...
|
NxStage Medical, Inc. (NXTM) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
2/3/2010 6:32:29 AM
More...
|
Manhattan Pharmaceuticals, Inc. (MHA) Announces Amendment of Joint Venture Deal With Nordic Biotech
6/13/2008 7:00:26 AM
More...
|
Manhattan Pharmaceuticals, Inc. (MHA) Announces Closing of Joint Venture With Nordic Biotech
2/27/2008 6:22:10 AM
More...
|
Manhattan Pharmaceuticals, Inc. (MHA) Announces Joint Venture With Nordic Biotech for Lead Product Hedrin
2/6/2008 11:01:33 AM
More...
|
iCeutica Inc. and Nordic Biotech Sign an Agreement to Reformulate and Commercialise Nano-Compounds Using iCeutica Inc.'s EON(TM) Platform
5/9/2007 12:42:28 PM
More...
|
|